Extended Viewer

Placeholder thumb

Subscribe

View transcript



Biodiversity 101 


16 mins listen January 19, 2024



Biodiversity is everywhere from food production to pharmaceutical drugs, so the biodiversity crisis puts both society and the global economy at risk. And while it is like the climate crisis in its cause, there are complexities and measurement difficulties that make the biodiversity crisis a distinct problem for investors to address compared to the climate crisis. On this episode we sat down with our colleague Arne Klug to understand where this complexity comes from and how can investors go about it when trying to include biodiversity in their investment practices.

Loading Biodiversity 101...

Featuring

Gabriela de la Serna

Associate, MSCI Research

Arne Philipp Klug

Vice President, MSCI Research

Related content


ESG Now Podcast

The world of ESG explored. A rotating cast of environmental, social, and governance researchers join hosts Mike Disabato and Bentley Kaplan as they discuss the most pressing news of the week. But in an enjoyable way.
COP-erating on Biodiversity Loss

This week we discuss the market’s embrace of biodiversity.
The Sustainability and Climate Trends to Watch for 2024

We think 2024 is going to be a big year! From extreme heat hitting home and work, to the frothy wonderland of AI bumping against data privacy risks and scarce talent, to the role that private capital is going to play in the climate transition, and so much more. Join us as we take a sneak peek at next year's sustainability and climate trends.
Biodiversity Comes to Kunming and Taiwan’s Semiconductors are Thirsty

As international delegates thrash out new targets to save biodiversity, the food industry could quickly become a pariah. And for Taiwan’s all-important semi-conductor manufacturers, water shortages are raising uncomfortable questions.